Earnings Preannouncement for 2025
Filed with SSE · · 2 pages · Chinese
Kexing Biopharm Co., Ltd. on 6ix
Earlier from Kexing Biopharm
- Announcement on Estimated Amount of Daily Related Transactions in 2026
- Announcement on Renewing Engagement of Accounting Firm
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of Ophthalmic Preparation GB10 Injection
- Indicative Announcement on Report on Results of Shareholders' Inquiry Transfer and Equity Change of Shareholders with Over 5% Shares Reaching 5% Integer Multiple
- Indicative Announcement on Pricing for Shareholders' Inquiry-based Transfer
Later from Kexing Biopharm
- Announcement on Progress in Repurchasing Shares through Call Auction
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of GB19 Injection
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on Signing Daily Related Party Transaction Agreements
- Announcement on Progress and Implementation Result of Shares Repurchase and Share Changes
Follow Kexing Biopharm into a list and get an email when it puts out news.
Follow Kexing Biopharm